We selected genes from 3 previously reported prognostic gene signatures plus ER-related genes and analyzed the expression of 197 genes in a training set of non-systemically treated, N-, T1/T2 (≤ 3 cm), ER+, breast cancer patients. Here, ESR1 is linked to breast carcinoma.